Report on Business

With the GV70, Genesis shows it is ready to battle the European manufacturers in the competitive luxury crossover segment. James Engelsman and Thomas Holland from Throttle House say the GV70 makes up for being a little down on performance with plenty of style and tech.

The pandemic has reminded Canadians of the value that advisors deliver. From keeping clients’ emotions in check during wild market gyrations to preparing them for the various life situations that may arise, advisors can make a big difference in helping Canadians keep their finances under control during the best and worst of times. Christine Timms, a former advisor who has written books on topics such as business and team building and succession planning, joins Pablo Fuchs, editor of Globe Advisor to discuss the strategies that will help advisors set themselves apart in the year to come and beyond.

A U.S. jury on Jan. 3 found Theranos founder Elizabeth Holmes guilty of conspiring to defraud investors in the blood testing startup, convicting her on four of 11 counts. Gloria Tso reports.

Russia has been deploying its military close to Ukraine's border, with videos shared online showing trains transporting armoured vehicles and convoys of military trucks. Moscow annexed the Crimean Peninsula in 2014 and supports separatists in Ukraine's east, while Ukraine is an aspiring NATO member.

Pent-up demand, overwhelmed U.S. ports and COVID-19 are affecting how goods are making their way to Canada. David Soberman from the Rotman School of Management says it could be months until a new equilibrium is found in global shipping and Canadian businesses and consumers need to be ready to adapt.

With only a few weeks remaining until the end of the year, what tax planning strategies do advisors need to consider for their clients before it’s too late for their 2021 tax returns? Globe Advisor editor Pablo Fuchs speaks with Jamie Golombek, managing director of tax and estate planning at CIBC Private Wealth about the tax tips advisors and their clients should take advantage of before the Dec. 31 deadline.

Human trials are set to begin on two new COVID-19 vaccines under development at McMaster University in Hamilton. The vaccine boosters are inhaled using a nebulizer and have three antigens, possibly increasing their effectiveness.